AP
HALO icon

AHL Partners’s Halozyme HALO Stock Holding History

AHL Partners’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$292K Buy
+14,402
New +$265K ﹤0.01% 1169
2016
Q4 		– Sell
-26,682
Closed -$322K – 1095
2016
Q3 		$322K Buy
+26,682
New +$273K 0.01% 966
2015
Q4 		– Sell
-10,566
Closed -$141K – 738
2015
Q3 		$141K Buy
+10,566
New +$212K 0.02% 673

Other funds holding HALO

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AHL Partners's HALO Position: Q4 2017 in Review

AHL Partners opened a new position in Halozyme (HALO) in Q4 2017: 14,402 shares worth $292K. The stake represents ﹤0.01% of the portfolio and ranks #1169 among its holdings. This is a return to the name: AHL Partners previously reported a position in HALO as recently as Q3 2016.

AHL Partners first reported a position in HALO in Q3 2015 and has held it in 3 quarters since. The position peaked at $322K in Q3 2016. 198 funds tracked by Wall St. Rank hold HALO as of Q4 2017.

  • AHL Partners held 14,402 shares of Halozyme worth $292K as of Q4 2017.
  • Halozyme was a new AHL Partners position in Q4 2017.
  • Halozyme made up ﹤0.01% of AHL Partners's portfolio in Q4 2017, its #1169 holding.
  • AHL Partners first reported a position in Halozyme in Q3 2015 and has held it in 3 quarters since.
  • AHL Partners's Halozyme position peaked at $322K in Q3 2016.
  • 198 funds tracked by Wall St. Rank held Halozyme as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.